Hematology
Conference Coverage
VIDEO: Marijuana may raise stroke risk
News
MAGELLAN trial results support rivaroxaban for DVT prophylaxis
Major Finding: At 10-day follow-up, 2.7% of both study groups had a thromboembolic event; at 35-day follow-up, 4.4% of subjects who received...
News
Double-unit cord blood transplants don't boost survival
Major Finding: Overall survival at 1 year after umbilical cord blood transplant was 71% with a single-unit transplant and 65% with a double-unit...
News
TOPPS: Limit prophylactic platelets to select groups
Major Finding: The primary endpoint of WHO grade 2 or higher bleeding was seen in 50% with no prophylaxis (151 of 300) and 43% receiving...
News
Beriplex outperforms plasma for rapid warfarin reversal
Major Finding: One hour after the start of infusion, roughly 70% of prothrombin complex concentrate recipients and less than 5% of plasma...
News
Good news for apixaban in recurrent VTE prevention
Major Finding: The composite primary efficacy endpoint of symptomatic VTE recurrence or all-cause death occurred in 3.8% of patients on apixaban 2...
Commentary
ASH12: Apixaban cuts risk of venous thromboembolism
News
Bullseye on Overuse: Fewer Interventions for Better Care
Conference Coverage
Stewardship Team Caught Drug Errors in Hospitalized HIV Patients
Major Finding: An antimicrobial stewardship team identified 26 errors associated with HIV-associated medications in 69 hospitalized patients with...
News
HPV Vaccine's Benefits Are Mainly Extracervical
Conference Coverage
TRILOGY: Prasugrel, Clopidogrel Look Similar in ACS Patients
Major Finding: Prasugrel showed no overall efficacy edge over clopidogrel in medically managed patients with non–ST-segment elevation acute...